免疫子制药(IMRN)

财报披露

免疫子制药(IMRN)07-03 18:15

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058780  Act: 34  Size: 297 KB 网页链接查看全文

财报披露

免疫子制药(IMRN)07-05 18:35

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-059244  Act: 34  Size: 58 KB 网页链接查看全文

财报披露

免疫子制药(IMRN)07-09 18:15

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-059911  Act: 34  Size: 5 MB 网页链接查看全文

生效批准

免疫子制药(IMRN)07-22 18:15

$免疫子制药(IMRN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002207  Act: 33  Size: 1 KB 网页链接查看全文

财报披露「修正」

免疫子制药(IMRN)05-28 18:05

$免疫子制药(IMRN)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-046748  Act: 34  Size: 17 MB 网页链接查看全文

财报披露

免疫子制药(IMRN)07-15 20:05

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-061171  Act: 34  Size: 99 KB 网页链接查看全文

财报披露

免疫子制药(IMRN)05-31 20:05

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-048181  Act: 34  Size: 13 MB 网页链接查看全文

财报披露

免疫子制药(IMRN)07-18 18:25

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-062303  Act: 34  Size: 4 MB 网页链接查看全文

增发股票注册声明

免疫子制药(IMRN)07-03 18:05

$免疫子制药(IMRN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-24-058720  Act: 33  Size: 953 KB 网页链接查看全文

财报披露

免疫子制药(IMRN)05-03 20:05

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-039317  Act: 34  Size: 76 KB 网页链接查看全文

倒霉一哥2020-06-09 23:52

$Immuron(IMRN)$ 700% 我还是太年轻了查看全文

品咖啡2020-06-09 21:23

$Immuron(IMRN)$ 前一分 百分之30几 后一分 百分之400查看全文

品咖啡2020-06-09 21:20

$Immuron(IMRN)$ 哦 天啊查看全文

F1watch2017-05-25 19:50

F-1/A - Immuron Ltd (0001660046) (Filer) Filed: 2017-05-25 AccNo: 0001615774-17-002679 Size: 93 KB 网页链接查看全文

Immuron(IMRN.US)盘前涨超12% 旗下产品获美国国防部资助

格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助，这一举措是为了研究口服免疫疗法的给药方案，以供美国军队使用。Immuron是一家处于临床阶段的医疗公司，专注于一种新型特异性... 网页链接

生效批准

$免疫子制药(IMRN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002207  Act: 33  Size: 1 KB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-062303  Act: 34  Size: 4 MB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-061171  Act: 34  Size: 99 KB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-059911  Act: 34  Size: 5 MB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-059244  Act: 34  Size: 58 KB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058780  Act: 34  Size: 297 KB 网页链接

增发股票注册声明

$免疫子制药(IMRN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-24-058720  Act: 33  Size: 953 KB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058180  Act: 34  Size: 167 KB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-049849  Act: 34  Size: 52 KB 网页链接

财报披露

$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-048181  Act: 34  Size: 13 MB 网页链接